AMA: New Recommendations To Protect Disaster Survivors
August, 2008 -- CHICAGO – To help injured disaster survivors that may be at risk for infection from blood-borne viruses or tetanus in the environment, new vaccine recommendations were released today in the latest issue of the American Medical Association (AMA) Disaster Medicine and Public Health Preparedness journal. The recommendations are co-published with the Centers for Disease Control and Prevention (CDC).
“Diseases and bacteria that cause disability and death, such as hepatitis B and tetanus, can be prevented by vaccines that are safe, effective and widely available," said James J. James MD, AMA Disaster Medicine and Public Health Preparedness journal editor-in-chief and AMA director of the Center for Public Health Preparedness and Disaster Response. “These vaccines may be overlooked in the aftermath of mass casualty events because attention is focused on management of trauma wounds."
A blood-borne virus may infect exposed wounds, abraded skin, body fluids, or tissue from injured persons. These new recommendations focus on prevention of infection with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and tetanus following mass casualty events.
The report was developed through consultation among immunization experts, physicians who specialize in trauma and emergency medicine, and public health epidemiologists.
The new mass casualty vaccine recommendations include the following:
* Hepatitis B virus: HBV vaccine should be given for exposures of open wounds.
* Hepatitis C virus: When open wounds are exposed to blood, it may be advisable to refer patients to a primary care provider to consider follow-up testing for HCV.
* HIV: Post-exposure prophylactic treatment for HIV is almost never indicated in mass casualty settings.
* Tetanus: If vaccination is not current, tetanus vaccine should be given for wounds received during mass casualty settings. If completion of a primary tetanus series is in doubt, tetanus immune globulin (TIG) should also be given. TIG is most likely to be needed by the elderly and immigrants from areas of the world other than North America and Europe.
These recommendations pertain only to bombings and other mass-casualty events and are not meant to take the place of existing recommendations for administering vaccines in other health care settings.
Source: AMA
Scroll down for related articles:
Related articles
- 2008-08-13: AMA: New Recommendations To Protect Disaster Survivors
- 2009-06-16: Novartis Cell-Based Technology For A(H1N1) Swine Flu Vaccine Production
- 2009-05-26: Sanofi Pasteur Receives Order from US Government to Produce New Influenza A(H1N1) (Swine Flu) Vaccine
- 2009-05-25: HHS Takes Additional Steps Toward Development of Vaccine for the Novel Influenza A H1N1 (Swine Flu)
- 2009-03-03: Scripps Research Scientists Engineer New Type of Vaccination that Provides Instant Immunity
- 2008-08-05: Senator Clinton: New HIV Estimates Underscore Need to Improve Response, Increase Prevention Efforts
- 2009-11-04: H1N1 Flu Questions and Answers
- 2009-11-04: HHS: Initial Results Show Pregnant Women Mount Strong Immune Response to One Dose of 2009 H1N1 Flu Vaccine
- 2009-11-04: World’s Largest Malaria Vaccine Trial Now Underway In Seven African Countries
- 2009-10-20: In Iowa's Interest: The H1n1 Vaccine
- 2009-10-01: Mass. Governor Patrick Announces First Shipment Of H1n1 Vaccine Will Arrive Next Week
- 2009-09-18: CDC: Nation′s Teen Vaccination Coverage Increasing